Soo Borson1, Malaz A Boustani2, Kathleen C Buckwalter3, Louis D Burgio4, Joshua Chodosh5, Richard H Fortinsky6, David R Gifford7, Lisa P Gwyther8, Mary Jane Koren9, Joanne Lynn10, Cheryl Phillips11, Martha Roherty12, Judah Ronch13, Claudia Stahl14, Lauren Rodgers15, Hye Kim16, Matthew Baumgart17, Angela Geiger18. 1. Department of Psychiatry & Behavioral Sciences, University of Washington, Seattle, WA, USA. 2. Indiana University Center for Health Innovation and Implementation Science, Sandra Eskenazi Center for Brain Care Innovation, Indianapolis, IN, USA. 3. D.W. Reynolds Center of Geriatric Nursing Excellence, College of Nursing, Oklahoma University Health Sciences Center, Oklahoma City, OK, USA. 4. Department of Psychology, University of Alabama, Tuscaloosa, AL, USA; Department of Psychology, Western Michigan University, Kalamazoo, MI, USA. 5. Division of Geriatric Medicine and Palliative Care, School of Medicine, New York University, New York, NY, USA. 6. Center on Aging, School of Medicine, University of Connecticut, Farmington, CT, USA. 7. Quality & Regulatory Affairs, American Health Care Association, Washington, DC, USA. 8. Department of Psychiatry & Behavioral Sciences, Duke University Center for Aging, Durham, NC, USA. 9. Geriatrician (retired), The Commonwealth Fund, New York, NY, USA. 10. Center for Elder Care & Advanced Illness, Altarum Institute, Washington, DC, USA. 11. Public Policy Department, Leading Age, Washington, DC, USA. 12. Office of the Executive Director, National Association of States United for Aging and Disabilities, Washington, DC, USA. 13. Erickson School, University of Maryland-Baltimore County, Baltimore, MD, USA. 14. Patient-Centered Initiatives, Society of Hospital Medicine, Philadelphia, PA, USA. 15. Boston Consulting Group, Chicago, IL, USA. 16. Public Policy Division, Alzheimer's Association, Washington, DC, USA. 17. Public Policy Division, Alzheimer's Association, Washington, DC, USA. Electronic address: mbaumgart@alz.org. 18. Constituent Relations Division, Alzheimer's Association, Chicago, IL, USA.
Abstract
INTRODUCTION: Under the U.S. national Alzheimer's plan, the National Institutes of Health identified milestones required to meet the plan's biomedical research goal (Goal 1). However, similar milestones have not been created for the goals on care (Goal 2) and support (Goal 3). METHODS: The Alzheimer's Association convened a workgroup with expertise in clinical care, long-term services and supports, dementia care and support research, and public policy. The workgroup reviewed the literature on Alzheimer's care and support; reviewed how other countries are addressing the issue; and identified public policies needed over the next 10 years to achieve a more ideal care and support system. RESULTS: The workgroup developed and recommended 73 milestones for Goal 2 and 56 milestones for Goal 3. DISCUSSION: To advance the implementation of the U.S. national Alzheimer's plan, the U.S. government should adopt these recommended milestones, or develop similar milestones, to be incorporated into the national plan.
INTRODUCTION: Under the U.S. national Alzheimer's plan, the National Institutes of Health identified milestones required to meet the plan's biomedical research goal (Goal 1). However, similar milestones have not been created for the goals on care (Goal 2) and support (Goal 3). METHODS: The Alzheimer's Association convened a workgroup with expertise in clinical care, long-term services and supports, dementia care and support research, and public policy. The workgroup reviewed the literature on Alzheimer's care and support; reviewed how other countries are addressing the issue; and identified public policies needed over the next 10 years to achieve a more ideal care and support system. RESULTS: The workgroup developed and recommended 73 milestones for Goal 2 and 56 milestones for Goal 3. DISCUSSION: To advance the implementation of the U.S. national Alzheimer's plan, the U.S. government should adopt these recommended milestones, or develop similar milestones, to be incorporated into the national plan.
Authors: Richard H Fortinsky; Laura N Gitlin; Laura T Pizzi; Catherine Verrier Piersol; James Grady; Julie T Robison; Sheila Molony Journal: Contemp Clin Trials Date: 2016-07-06 Impact factor: 2.226
Authors: Richard A Goodman; Kimberly A Lochner; Madhav Thambisetty; Thomas S Wingo; Samuel F Posner; Shari M Ling Journal: Alzheimers Dement Date: 2016-05-10 Impact factor: 21.566